Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Cureus|December 14, 2022
Autoimmune Myelitis and Myocarditis in a Patient With Anti-Aquaporin-4, Antinuclear, and Antiphospholipid Autoantibodies: The Neuromyelitis Optica-Systemic Lupus Erythematosus (NMO-SLE) Overlap SyndromeEdward C Mader, Olinda Verdecie, Vaniolky Losada, et al.Clinical Neurology and Neurosurgery|October 14, 2021
Altered mental status predicts length of stay but not death in a community-based cohort of hospitalized COVID-19 patientsDavid Chachkhiani, Marine Isakadze, Nicole R Villemarette-Pittman, et al.International Journal of MS Care|August 25, 2017
Cultural Adaptation, Validity, and Factor Structure of the Jalowiec Coping Scale in Iranian Women with Multiple Sclerosis: Which Coping Strategies Are Most Common and Effective?Mohsen Saffari, Hormoz Sanaeinasab, Mahrokh Hashempour, et al.Journal of the Neurological Sciences|January 11, 2015
Tumefactive multiple sclerosis and hepatitis C virus 2a/2C infection: Dual benefit of long-term interferon beta-1a therapy?Edward C Mader, Wael Richeh, Joaquin Maury Ochoa, et al.Archives of Physical Medicine and Rehabilitation|July 20, 2015
Cognitive Impairment and Community Integration Outcomes in Individuals Living With Multiple SclerosisAbbey J Hughes, Narineh Hartoonian, Brett Parmenter, et al.Clinical Neurology and Neurosurgery|September 3, 2020
Neurological complications in a predominantly African American sample of COVID-19 predict worse outcomes during hospitalizationDavid Chachkhiani, Michael Y Soliman, Delphi Barua, et al.Data in Brief|March 10, 2021
Neurological complications of COVID19 during March 2020 at LCMC health university medical center: DatasetDavid Chachkhiani, Michael Y Soliman, Delphi Barua, et al.Journal of Sleep Research|January 18, 2017
Sleep and its associations with perceived and objective cognitive impairment in individuals with multiple sclerosisAbbey J Hughes, Brett A Parmenter, Jodie K Haselkorn, et al.Neurology|September 8, 2012
Ginkgo biloba does not improve cognitive function in MS: a randomized placebo-controlled trialJesus F Lovera, Edward Kim, Elizabeth Heriza, et al.Pageof 1